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Abstract
The study of the aging process and its prevention is an incredibly popular field; the natural course of the human body is to age
and theories abound on how to avoid it. Age affects every system and pathway of the body and alters many of the bodily functions. This paper, using articles from Touro’s library database examines the different areas in which aging negatively affects ATP
production.The multifaceted process associated with the production of ATP in the human body was analyzed. Several features such
as the mitochondria, physical activity, and hormones are linked to ATP production and the relationship was further explored. The
findings reveal that a dysfunction or lack of these factors, a feature of aging, is the initiator of the decrease in ATP production that
is attributed to the natural aging process. Together, a lack of mitochondrial function, physical inactivity, reduced growth hormone
levels, and increased insulin sensitivity levels contribute to the decline in ATP production that is concomitant with the progression
of age. The diminishing presence of ATP then stimulates further dysfunction or lack of these elements, which in turn drives the
aging process even further.
Introduction
Aging is a phenomenon that all creatures go through. It is believed to be a degenerative process caused by accumulated
damage that leads to cellular dysfunction, tissue failure and
death. The physiological changes which lead to senescence in
humans may involve spine curving (kyphosis), reduced fertility,
loss of hearing and eyesight, frailty, cognitive decline and many
other symptoms (Trifunovic et. al., 2004). All these changes in
the body are triggered by a variety of molecular and biochemical modifications. One of the major pathways that is altered as
people age is the cellular respiration pathway which produces
ATP, the body’s main source of energy.

Methods
The research discussed in this paper was collected from various
different databases. The majority of the articles were compiled
from databases such as PubMed and ProQuest, with access to
restricted articles gained by using Touro’s library system. Some
articles were also found through google scholar.

An Overview of Cellular Respiration
Cellular respiration is a set of metabolic reactions to convert
biochemical energy from nutrients into adenosine triphosphate
(ATP). ATP is the primary energy carrier in living organisms.
When the cell requires energy, it breaks down ATP through
hydrolysis; a high energy bond is broken where a phosphoryl
group is removed and energy is released. In humans, aerobic
cell respiration has three parts. Glycolysis is the breakdown of
glucose into two pyruvate molecules where two molecules of
ATP and two molecules of NADH are produced without necessitating oxygen. The next step is known as the Krebs cycle,
the citric acid cycle or the tricarboxylic acid cycle. The carbons
in the pyruvate molecules are pulled apart and the energy
stored in those covalent bonds is released. This step produces
two molecules of ATP, six NADH molecules and two FADH2
molecules. The third and final step is the electron transport
chain and oxidative phosphorylation. Here, oxygen is required
and about thirty-four molecules of ATP are produced. The
second two steps of cellular respiration, which are the main
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energy-producing steps, occur in the mitochondria, unlike glycolysis which takes place in the cytoplasm (Fernie et. al., 2004).
Oxidative phosphorylation is the metabolic pathway in which
cells use enzymes to oxidize nutrients. Electrons are fed from
reduced substrates such as NADH, FADH2, fatty acids or glycerol phosphates into the electron transport chain located in
the inner membrane of the mitochondria. Big membrane-bound
enzymes such as the dehydrogenases of b-oxidation, glycerol
phosphate dehydrogenase, NADH-Q oxidoreductase (Complex
I) or succinate-Q oxidoreductase (Complex II) pass electrons
down the gradient of redox potential to ubiquinone (Q) which
is a mobile lipid-soluble carrier. The electrons then get passed
down from ubiquinone to the final acceptor, oxygen, through
Q-cytochrome c oxidoreductase (Complex III), cytochrome c
(a second, water-soluble, mobile carrier) and cytochrome c oxidase (Complex IV). As the electrons move from less electronegative to more electronegative molecules, they lose energy, and
with that energy, Complex I, Complex III and Complex IV pump
protons against their electrochemical gradient from the matrix
to the intermembrane space. A protonmotive force, consisting
mostly an electrical gradient (membrane potential) and a small
chemical gradient, (pH difference) is set up due to the pumping
of protons. This protonmotive force then pushes the protons
back into the matrix through the ion channel ATP synthase
which harvests the energy and creates ATP (Saraste, 1999).
Being that the main organelle involved in cellular respiration
is the mitochondrion, dysfunction of this organelle must be the
driving force behind the lack of energy in cells, resulting in cell
death. This implies that dysfunctional mitochondria must be of
central focus in aging.The decline of mitochondrial function with
age has been recognized for some time and has been linked to
a decreased number of mtDNA and mitochondrial protein levels in human heart, brain and skeletal muscle cells. Additionally,
aged muscle suffers from functionally impaired respiratory
chain units, inhibiting respiration associated with ATP production (Zapico et. al., 2016).The mitochondria in elderly tissue has
often been found to be larger, fewer in number and contain abnormal cristae, vacuoles and paracrystalline inclusions (Hutter
et. al., 2007). When the quadriceps of thirty participants whose
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ages ranged from 78.5 ± 5. years were examined, an inverse relationship between the fatiguability level and the level of oxidative
phosphorylation (ATPmax) was reported. Higher fatigue levels,
a condition which is extremely common with advancing age,
is caused by a decrease in mitochondrion capacity for oxidative phosphorylation (Santanasto et. al., 2014). In another study,
permeabilized muscle fibers from the vastus lateralis were studied from twenty-four young (approximately thirty years) and
thirty-one older (approximately sixty-five years) subjects. This
study was to determine if there was a change in mitochondrial
respiratory capacity and coupled respiration (respiration linked
to ATP production) with age and the results showed a decline
in both (Porter et. al., 2015). There are many possible reasons
for this decline in mitochondrial function but the most accepted
theory seems to be the Free Radical Theory of Aging.

Mitochondrial Free Radical Theory of Aging
Oxidative damage is a main cause of cell degeneration. Since the
mitochondria are involved in many redox reactions, they are
extremely prone to oxidative stress. The source of oxidative
damage is the free radicals known as oxidants or reactive oxygen species (ROS) which are a byproduct of redox-reaction and
therefore produced during aerobic respiration (Harman, 1956).
Normally, a small fraction of the oxygen consumed by the mitochondria is converted into reactive oxygen species, but defects
in the respiratory chain lead to greater production of these free
radicals (Lee et. al., 2000). Superoxide Dismutase (SOD), an
enzyme whose activity is present in subcellular compartments
where there is O−2⋅ formation, was used as a tool to reveal
that the mitochondria are a principle source of endogenous oxidants. Some of the SOD activity was recognized in the matrix
space and the other half in the inner and outer membranes of
the mitochondria (Imray, Fridovich, 1991).
Ground state diatomic oxygen is not too reactive itself because
its two unpaired electrons are located in different molecular orbitals and possess parallel spins. As a result, in order for O2 to
simultaneously accept two electrons, they must both possess antiparallel spins relative to the unpaired electrons. Consequentially,
O2 preferentially accepts electrons one at a time from other
radicals (such as transition metals in certain valences). In living
organisms, therefore, oxygen must participate in coordinated,
serial, enzyme-catalyzed one-electron reductions in order to be
reduced by two or four electrons. The enzymes that carry out
these reactions generally possess active-site radical species such
as iron. This method of O2 reduction generates O−2⋅ and hydrogen peroxide (H2O2).When in the company of free transition
metals (specifically iron and copper), O−2⋅ and H2O2 together
produce the hydroxyl radical (⋅OH) (Wood, 1988).This extremely reactive radical is presumed to be the species responsible for
initiating the oxidative destruction of biomolecules (Harman,
1956). When mitochondrial DNA of cells which can no longer

reproduce undergoes oxidative damage it results in mutations
and blocks in replication, leading to mitochondrial dysfunction
and ultimately a decline in ATP production.
One study demonstrated that older people have significantly
higher oxidative damage to DNA and that mtDNA abundance
decreases with age.The decrease in mtDNA is attributed to the
lessened content of mRNA transcripts that encode mitochondrial protein. The skeletal muscle of the elderly population was
found to contain a reduced amount of mitochondrial proteins
and oxidative enzymes (enzymes that catalyze redox reactions
and increase the rate at which ATP is produced aerobically).
Accumulated oxidative damage can be the reason for lessened
mtDNA content in aging muscle. DNA oxidation, the process of
oxidative damage on Deoxyribonucleic Acid, was observed to
increases with age. Also, there is a higher activity of antioxidant
enzymes in older rat muscles, indicating that the ROS production rate increases with age; the ROS production rate surpasses
the activity of the antioxidants defense enzymes (Short et. al.,
2005). The decline in mtDNA content is a contributing factor
to dysfunctional mitochondria because it means that there is a
lack of template availability for transcription and translation of
crucial mitochondrial proteins. The reduction of mitochondrial
protein synthesis and oxidative enzyme activity helps explain
the reduced ability of mitochondria to perform oxidative phosphorylation in older muscle. This study concluded that there is
a decline in mitochondrial ATP production rate (MAPR), and its
point of validity comes from the fact that the subjects were well
suited for the study. They had a large group of one hundred and
forty-six healthy men and women ranging in age from nineteen
to eighty-nine.Their physical activity was taken into account and
they were subjects who were not regularly doing exercise (less
than thirty minutes less than two days a week). In response to
the studies which show that physical activity improves muscle
mitochondrial biogenesis, the physical activity of the subjects
was taken into account. Only men and women who were not
regularly exercising, with activity totaling less than thirty minutes for less than two days a week, were chosen. Also, the
participants were kept on a standard diet for three days before muscle biopsies from their vastus lateralis were taken for
study. A key finding of this study was the decline in the MAPR
of skeletal muscle with age due to a combination of reduced
mitochondrial content and a functional alteration in the existing
mitochondrial population (Short et. al., 2005).
In response to the production of ROS, uncoupling agents such
as dinitrophenol (DNP) are produced.These agents are lipid-soluble weak acids that can cross the mitochondrial membrane.
Once inside the mitochondria, these proteins eliminate the link
between oxidation and phosphorylation. They accomplish this
by setting up a catalytic cycle that dissipates the protonmotive force, allowing the continuation of substrate oxidation all
the while lacking the driving force for coupled ATP synthesis.
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This is a thermogenic process and occurs in many living cells
including skeletal muscle cells (Brand, 2000). The first known
UCP, UCP1 is the one that controls brown fat which is one of
the body’s ways of regulating thermogenesis. In the brown adipose tissue, the proton leak through UCP1 is a mechanism that
exploits energy generally used to create ATP to generate heat.
This method of thermogenesis regulated by brown fat UCP1 is
important in numerous physiological conditions such as arousal
from hibernation and cold exposure in newborns. The question
of the reason for this process arises. What reason is enough to
validate a reduction in ATP level and such a high energetic price?
To strengthen this question, it is known that thermogenesis is
not enough of motivation because this uncoupling process is
done by both endotherms and ectotherms. The reasoning behind this seemingly troubling process is the diminution of ROS
production, a protection against cellular degeneration (Brand,
2000). When calculated, the respiratory capacity used for phosphorylation and respiratory function linked to ATP production
in older adults was lower than in the young (Porter et. al., 2015).
Not only do the presence of free radicals (which are a result of
aging) lower the skeletal muscle ATP production, but the cell’s
natural response and method to protect itself against oxidative
damage, which involves uncoupling proteins, is also a major contributing factor to the reduction of ATP production.
A more indirect but lethal effect oxidants have on the mitochondria is that they disrupt the activity of the lysosomes.
Oxidative damage is responsible for depositing lipofuscin in
the lysosomes. Lipofuscin us the yellow pigment granules made
up of lipid residues of lysosomal digestion, and accumulation
of lipofuscin alters the lysosomal autophagic ability. Because
the lysosomes take care of recycling unnecessary material and
organelles (such as viruses or damaged particles), their failure
results in a buildup of unwanted particles in the cell (Konig et.
al., 2017). Decreased macroautophagic activity from lysosomal
leakage was observed in rat cells, and is a central reason for
the accumulation of damaged mitochondria in aged cells. This
buildup is associated with a decrease in mitochondrial efficiency and an increase in oxidant generation (Roberg, Ollinger,
1998). The decline in autophagic activity as a common characteristic of aging makes for clogged lysosomes due to lipofuscin
and mitochondrial deterioration. This process in which mitochondrial ROS encourage lipofuscin generation while the accumulation of lipofuscin disturbs the mitochondrial autophagy
is known as the “garbage catastrophe theory of aging” (Hutter
et. al., 2007).
Therefore, oxidative destruction of molecules involved in
aerobic respiration (such as oxidative enzymes, mitochondrial
proteins or mtDNA) leads to defective mitochondria. The mitochondria themselves are primary targets of oxidative damage
and increase their production of ROS once destroyed. Putting
these two processes together results in a disastrous vicious

60

cycle in which the synthesis of malfunctioning electron transport chain subunits results in oxidative phosphorylation impairment, decreased ATP production and further ROS generation.

Physical Activity
There are many studies which say that the primary contributing
factor to reduced mitochondrial function is the lack of physical
activity. In one study, thirty-nine volunteers were to complete
graded exercise tests to determine their daily physical activity,
fitness, and exercise efficiency. The group of volunteers included
ten young active people about thirty years old, ten older active
people about sixty-seven years old and nineteen older sedentary
people. Mitochondrial energetics from biopsies of the vastus lateralis were measured via magnetic resonance spectroscopy and
respirometry. The results of this study showed a higher fitness
level in the young active compared to the older active and older
sedentary.The mitochondrial respiration, maximum mitochondrial capacity, Maximal ATP production/Oxygen consumption (P/O)
ratio, and exercise efficiency were similar in the young active and
older active and were significantly lower in older sedentary. This
study concluded that constant physical activity makes for better
mitochondrial capacity (Distefano et. al., 2018).
Besides for physical activity having an effect on the mitochondrial efficiency (ATPmax/max O2 consumption), the reverse is
also true. Lessened mitochondrial efficiency seems to have a
negative effect on older peoples’ physical activity. A study was
done to analyze whether or not slower walking speed in older
adults is related to reduced mitochondrial capacity and efficiency. A group of thirty-seven older people (ages ranging from
seventy to eighty-nine) who were of normal weight (under 286
lb for the men and under 251 lb. for the women) were chosen.
They were able to walk unassisted and had no symptoms of
cardiovascular or pulmonary disease. They had no pain or stiffness in the legs, hips, knees, feet, or ankles when walking and no
difficulty bending or straightening the knees. The participants
were told to complete a 400-meter walk within 15 minutes at
their normal walking speed. Afterward, muscle fibers biopsies
from the vastus lateralis were taken to be observed. A key finding was that muscle mitochondrial efficiency correlated with the
participants walking speed.This study concluded that the loss of
mitochondrial capacity and efficiency with age may be important contributors to the reduction in mobility and increase in
disability. This is due to the relationship between mitochondrial
capacity and walking speed (Coen et. al., 2012).
The link between physical activity and mitochondrial energetics is that aerobic exercise enhances muscle mitochondrial
biogenesis. Resistance training in older people can increase
the protein synthesis rate. The content and function of certain
proteins in the muscle which are vital to its functioning, depend on the protein synthesis rate (Short et. al., 2005). Exercise
counteracts decay which happens in aging muscle by heightening
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muscle protein turnover. Because muscle mitochondrial content
and function is reduced with age, the resting and maximal oxygen consumption also decline with advancing age (Short et. al.,
2004). The VO2max of an individual is closely associated with
mitochondrial ATP production and so a decline in the VO2max
with age means that it is correlated with a decline in ATP production. In muscle samples taken from healthy individuals ranging
from eighteen to eighty-seven years, the VO2max while cycling
declined approximately eight percent per decade (Short et. al.,
2005). If constant physical activity throughout one’s life is what
can keep the VO2max at a decent level, it must be that physical
decline, a common occurrence in aging, is in part a contribution
to the reduction of ATP production.

Sarcopenia and Physical Decline
Sarcopenia, a natural part of the aging process, is the progressive
decline of muscle mass, strength and physical function. The loss
rate is believed to accelerate after the age of sixty-five. The deterioration of muscle quantity and quality leads to a decline in
strength and power and a slowing of movement, all features of
sarcopenia (Baumgartner et. al., 1999). A deterioration in muscle
mass is followed by a decline in physical activity which has been
negatively linked to mitochondrial function.
Age-related hormonal changes seem to be a possible mechanism for the onset of sarcopenia. Insulin-like growth factor
1 (IGF-1) is a protein that is encoded by the IGF-1 gene. This
hormone plays a fundamental role in childhood growth and
continues to have anabolic effects in adulthood. The production
of IGF-1 is stimulated by growth hormone. Growth hormone
(GH) is made in the anterior pituitary gland, released into the
blood stream, and then stimulates the liver to produce IGF1. IGF-1 is the stimulation for systemic body growth, and has
proliferating effects on many cells in the body, especially skeletal
muscle (Laron, 2001). After twenty years of age, the secretion of
growth hormone decreases by approximately fourteen percent
per decade. This decline is followed by a reduction in IGF-1,
which is responsible for cell production, energy metabolism, and
inhibition of apoptosis (Giannoulis et. al., 2008).
Testosterone, an anabolic steroid which increases muscle
protein synthesis, begins to drops in male serum levels in the
late thirties and continues to decline throughout adulthood. A
group of older men were treated with testosterone in order
to increase their testosterone level to that of younger men.
The treatment attenuated one symptom of sarcopenia, the loss
of muscle mass (Storer et. al., 2016). In females, the positive
correlation between plasma estrogen levels and muscle mass
suggests that reduced estrogen following menopause may result
in reduced muscle mass as well (Van Geel et. al., 2009).
Although there was no change in muscle mass or strength
when healthy males were treated with GH alone, the addition

of testosterone to the treatment resulted in a 6.8% increase in
muscle strength. There was also an increase in lean body mass
(LBM=total body weight minus the fat) which indicates the correlation between lean body mass and strength; a change in LBM
results in a change in strength. Along with increase in LBM came
an increase in VO2max. (Blackman et. al., 2002). An effective
mechanism to increase the endogenous levels of somatotropic
hormones (such as GH and IGF-1) in the blood is training and
exercise. A thirteen-week combined sprint and resistance training in middle-aged men improved the body composition and
increased circulating GH. There was also an increase in IGF-1
level following the exercise which shows that training can counteract the natural decline in somatotropic hormones during
aging (Sellami et. al., 2017). A decrease in GH and testosterone,
vital anabolic hormones, plays a big role in the loss of muscle
mass which is a key element in the development of sarcopenia.
Another possible cause of sarcopenia is the acceleration of
apoptotic pathways. Apoptosis is the highly regulated and controlled process of cell death in multicellular organisms. This process can happen via the intrinsic pathway in which the cell kills
itself because it senses cell stress, or the extrinsic pathway, where
the cell kills itself because of signals from the other cells. Both
pathways initiate the activity of caspases, enzymes that destroy
proteins. Apoptosis is a homeostatic process which keeps our
body balanced between all the new cells arising from stem cells
and the billions of cells dying each day.This very beneficial process
becomes a problem when it accelerates with age and results in
the loss of muscle mass and strength.Although the mechanism for
the acceleration of these pathways is unknown, what is known is
that there are many contributing factors such as oxidative stress
and impaired insulin sensitivity (Marzetti et. al., 2012).

Insulin Resistance
A major finding in old age is insulin resistance. Insulin is a hormone produced by the pancreas and regulates the amount of
glucose in the blood. Resistance to this hormone can result in
type 2 diabetes. Age associated decline in mitochondrial function seems to be related to insulin resistance. The MAPR was
found to be approximately thirty percent less in patients who
were insulin resistant compared to those who were not, and
that was consistent with the finding of altered mitochondria
(Petersen et. al., 2004). The altered mitochondria and reduced
MAPR is known to be a contributing factor to insulin resistance.
In addition to that, insulin stimulates transcription and translation of mitochondrial proteins and genes thereby increasing
MAPR and this effect is lacking in those with type 2 diabetes. So,
whether insulin resistance causes a decrease in mitochondrial
function or the reverse, both possibilities are plausible for they
seem to each have an effect on the other (Short et.al., 2005).
In a study done to determine if insulin enhances the capacity of
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mitochondrial ATP production in skeletal muscle, both subjects
with and without type 2 diabetes were recruited and muscle biopsies of the vastus lateralis were examined. The muscles were
infused with a low dosage of insulin and a high dosage of insulin
and were studied after eight hours. Mitochondrial protein complexes, whose syntheses are dependent on coordinated transcriptional regulation of mitochondrial and nuclear genes, must
be available for mitochondrial ATP production to occur. In the
subjects without diabetes, the high dose insulin infusion resulted
in a higher mitochondrial fractional synthesis rate. Additionally,
there was an increase in the activities of the oxidative enzymes
citrate synthase and cytochrome-c¬-oxidase subunit IV (a part
of complex IV). (Citrate synthase is the pace-making enzymes of
the first step in the citric acid cycle and increased activity of the
citric acid cycle may increase the rate of ATP production.) There
was also an increase in the mRNA level from both mitochondrial (NADH dehydrogenase subunit IV) and nuclear (cytochrome
c oxidase subunit IV) genes encoding mitochondrial proteins.
After eight hours of high dose insulin infusion, the mitochondrial ATP production rate of the individuals with type 2 diabetes
did not change. Clearly, insulin infusion increases mitochondrial
protein synthesis and the mitochondrial capacity for oxidative
phosphorylation in skeletal muscle (Stump et. al., 2003). Insulin
is not only important for regulating the blood sugar level but
it is also heavily involved in ATP production. Resistance to this
hormone, resulting from dysfunctional mitochondria, causes a
decrease in mitochondrial protein content thus reducing mitochondrial respiration and ATP production.

Conclusion
The free radical theory of aging which gives reason for the malfunctioning mitochondria is itself a result of dysfunctional mitochondria. Increased ROS production, a byproduct of mitochondrial decay disrupts lysosomal activity creating the additional
accumulation of damaged mitochondria followed by an increase
in oxidants. An additional result of oxidative damage is the decrease in muscle mass, muscle strength and movement. The opposite is also true, physical activity has been shown to increase
muscle mass and counteract the production of free radicals
(ROS) while physical inactivity has shown to increase ROS levels, increase sarcopenia and decrease insulin sensitivity. Insulin
resistance is another result of oxidant accumulation and physical inactivity and causes additional ROS content by disturbing
mitochondrial protein synthesis. Essentially, all of these factors
are negative feedback loops that influence each other. Studies
which failed to see the correlation between these features and
decreased ATP production with age, may be because they failed
to look at all of these factors as a whole and recognize that
when they all come together, create a vicious cycle. Although
it is unclear how and where this natural process starts, once it
does, there is no way to end it. The decrease in ATP production
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in skeletal muscle is an ordinary part of the aging process which
results in driving the aging process even further.
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